339 related articles for article (PubMed ID: 33931247)
1. ABO Blood Incompatibility Positively Affects Early Graft Function: Single-Center Retrospective Cohort Study.
Watari S; Araki M; Wada K; Yoshinaga K; Maruyama Y; Mitsui Y; Sadahira T; Kubota R; Nishimura S; Kobayashi Y; Takeuchi H; Tanabe K; Kitagawa M; Morinaga H; Kitamura S; Sugiyama H; Wada J; Watanabe M; Watanabe T; Nasu Y
Transplant Proc; 2021 Jun; 53(5):1494-1500. PubMed ID: 33931247
[TBL] [Abstract][Full Text] [Related]
2. Association between response to rituximab and antibody-mediated rejection in ABO-incompatible living kidney transplantation.
Maenosono R; Unagami K; Kakuta Y; Furusawa M; Okumi M; Azuma H; Ishida H; Tanabe K
Int J Urol; 2019 Dec; 26(12):1114-1120. PubMed ID: 31522467
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcomes of ABO-incompatible kidney transplant with rituximab and double-filtration plasmapheresis.
Han S; Hwang E; Park S; Park U; Kim H; Cho W
Exp Clin Transplant; 2014 Oct; 12(5):401-4. PubMed ID: 25299367
[TBL] [Abstract][Full Text] [Related]
4. Long-term results of ABO-incompatible living kidney transplantation: a single-center experience.
Tanabe K; Takahashi K; Sonda K; Tokumoto T; Ishikawa N; Kawai T; Fuchinoue S; Oshima T; Yagisawa T; Nakazawa H; Goya N; Koga S; Kawaguchi H; Ito K; Toma H; Agishi T; Ota K
Transplantation; 1998 Jan; 65(2):224-8. PubMed ID: 9458019
[TBL] [Abstract][Full Text] [Related]
5. Histological Analysis in ABO-Compatible and ABO-Incompatible Kidney Transplantation by Performance of 3- and 12-Month Protocol Biopsies.
Masutani K; Tsuchimoto A; Kurihara K; Okabe Y; Kitada H; Okumi M; Tanabe K; Nakamura M; Kitazono T; Tsuruya K;
Transplantation; 2017 Jun; 101(6):1416-1422. PubMed ID: 27391195
[TBL] [Abstract][Full Text] [Related]
6. ABO-incompatible pediatric kidney transplantation without antibody removal.
Kawamura T; Hamasaki Y; Takahashi Y; Hashimoto J; Kubota M; Muramatu M; Itabashi Y; Hyodo Y; Ohashi Y; Aikawa A; Sakai K; Shishido S
Pediatr Nephrol; 2020 Jan; 35(1):95-102. PubMed ID: 31673829
[TBL] [Abstract][Full Text] [Related]
7. Outcome of ABO Blood Type-Incompatible Living-Related Donor Kidney Transplantation Under a Contemporary Immunosuppression Strategy in Japan.
Hamano I; Hatakeyama S; Fujita T; Murakami R; Hamaya T; Togashi K; Suzuki Y; Yamamoto H; Yoneyama T; Yoneyama T; Hashimoto Y; Narumi S; Tomita H; Ohyama C
Transplant Proc; 2020; 52(6):1700-1704. PubMed ID: 32448659
[TBL] [Abstract][Full Text] [Related]
8. Isoagglutinin adsorption in ABO-incompatible transplantation.
Genberg H; Kumlien G; Wennberg L; Tydén G
Transfus Apher Sci; 2010 Oct; 43(2):231-5. PubMed ID: 20667787
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of blood group antibodies in ABO-incompatible living-donor kidney transplantation.
Sugiyama K; Hyodo Y; Aikawa A
Int J Urol; 2015 Oct; 22(10):931-6. PubMed ID: 26108258
[TBL] [Abstract][Full Text] [Related]
10. Improved graft survival in ABO-incompatible living donor kidney transplantation.
Kaihara S; Okamoto M; Akioka K; Ogino S; Higuchi A; Kadotani Y; Nobori S; Yoshimura N
Transplant Proc; 2005 May; 37(4):1804-5. PubMed ID: 15919472
[TBL] [Abstract][Full Text] [Related]
11. ABO-incompatible kidney transplantation using both A2 and non-A2 living donors.
Gloor JM; Lager DJ; Moore SB; Pineda AA; Fidler ME; Larson TS; Grande JP; Schwab TR; Griffin MD; Prieto M; Nyberg SL; Velosa JA; Textor SC; Platt JL; Stegall MD
Transplantation; 2003 Apr; 75(7):971-7. PubMed ID: 12698082
[TBL] [Abstract][Full Text] [Related]
12. ABO-incompatible transplantation without conventional induction immunosuppression (IL-2RB or depleting agents).
Hafeeq B; Aziz F; Narayanan S; Aboobacker IN; Gopinathan JC; Narayanan R; Binu JJ; Uvais NA
Saudi J Kidney Dis Transpl; 2020; 31(3):572-581. PubMed ID: 32655043
[TBL] [Abstract][Full Text] [Related]
13. ABO-incompatible living donor kidney transplantation without post-transplant therapeutic plasma exchange.
Yabu JM; Fontaine MJ
J Clin Apher; 2015 Dec; 30(6):340-6. PubMed ID: 25739580
[TBL] [Abstract][Full Text] [Related]
14. Favorable results in ABO-incompatible renal transplantation without B cell-targeted therapy: Advantages and disadvantages of rituximab pretreatment.
Okada M; Watarai Y; Iwasaki K; Murotani K; Futamura K; Yamamoto T; Hiramitsu T; Tsujita M; Goto N; Narumi S; Takeda A; Morozumi K; Uchida K; Kobayashi T
Clin Transplant; 2017 Oct; 31(10):. PubMed ID: 28792635
[TBL] [Abstract][Full Text] [Related]
15. Transplantation of ABO-incompatible and living unrelated donor-recipient combinations.
Ishikawa N; Yagisawa T; Sakuma Y; Fujiwara T; Nukui A; Yashi M; Miyamoto N
Transplant Proc; 2008 Sep; 40(7):2292-3. PubMed ID: 18790215
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of two different preconditioning regimens for ABO-incompatible living kidney donor transplantation. A comparison of splenectomy vs. rituximab-treated non-splenectomy preconditioning regimens.
Tanabe K; Ishida H; Shimizu T; Omoto K; Shirakawa H; Tokumoto T
Contrib Nephrol; 2009; 162():61-74. PubMed ID: 19001814
[TBL] [Abstract][Full Text] [Related]
17. Impact of HLA-identity on results of ABO-incompatible living kidney transplantation.
Shimmura H; Tanabe K; Tokumoto T; Ishida H; Ishikawa N; Miyamoto N; Shimizu T; Shirakawa H; Setoguchi K; Teraoka S; Toma H
Transplant Proc; 2004 Sep; 36(7):2172-4. PubMed ID: 15518790
[TBL] [Abstract][Full Text] [Related]
18. Three-year outcomes following 1420 ABO-incompatible living-donor kidney transplants performed after ABO antibody reduction: results from 101 centers.
Opelz G; Morath C; Süsal C; Tran TH; Zeier M; Döhler B
Transplantation; 2015 Feb; 99(2):400-4. PubMed ID: 25050471
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the prevalence of systemic de novo thrombotic microangiopathy after ABO-incompatible kidney transplantation and the associated risk factors.
Tasaki M; Saito K; Nakagawa Y; Imai N; Ito Y; Yoshida Y; Ikeda M; Ishikawa S; Narita I; Takahashi K; Tomita Y
Int J Urol; 2019 Dec; 26(12):1128-1137. PubMed ID: 31587389
[TBL] [Abstract][Full Text] [Related]
20. Single fixed low-dose rituximab as induction therapy suppresses de novo donor-specific anti-HLA antibody production in ABO compatible living kidney transplant recipients.
Tomita Y; Iwadoh K; Ogawa Y; Miki K; Kato Y; Kai K; Sannomiya A; Koyama I; Kitajima K; Nakajima I; Fuchinoue S
PLoS One; 2019; 14(10):e0224203. PubMed ID: 31644555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
